SYT7 and Behcet disease: After being treated with clinical BD drugs such as olanzapine, which could induce a significant extracellular release of glutamate in mice by inhibiting the activity of the catabolic enzyme D-aspartate oxidase, it could efficiently prevent the behavioral abnormalities of Syt7 knockout mice [404].